DR. MARCUS ROGGEN
Professor Glenn Sammis
PROFESSOR
GLENN SAMMIS

COMPLEX BIOTECH DIVERSITY VENTURES

A licensed cannabis and psilocybin research laboratory.

Founded by award-winning chemists, CBDV focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. CBDV was granted a Section 56 exemption from Health Canada to commence their work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

A Strong IP Portfolio

Analytical tools for psychedelic mushroom compounds that advance clinical and end-user testing. Development of psilocybin analogs that could be used in future medical treatments. New projects like “Advanced Analytical Service” and “The Compound Database” will bring scalable revenue streams. The “Extraction Optimization AI” is now starting to be rolled out to the first customers.

Established History of Providing Research and Laboratory Services

CBDV has a history of profitability. Current and past customers are well-established global enterprises who require the cutting-edge cannabis and soon, psilocybin research, which CBDV provides.

Management Expertise

The founding team of CBDV originates from research groups at world-renowned academic institutions. This background instilled an ethos of intellectual curiosity and aspirations of understanding complex concepts through experimentation, research, and analysis.

DR. MARCUS ROGGEN
Professor Glenn Sammis
GLENN SAMMIS

COMPLEX BIOTECH DIVERSITY VENTURES

A licensed cannabis and psilocybin research laboratory.

Founded by award-winning chemists, CBDV focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. CBDV was granted a Section 56 exemption from Health Canada to commence their work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

A Strong IP Portfolio

Analytical tools for psychedelic mushroom compounds that advance clinical and end-user testing. Development of psilocybin analogs that could be used in future medical treatments. New projects like “Advanced Analytical Service” and “The Compound Database” will bring scalable revenue streams. The “Extraction Optimization AI” is now starting to be rolled out to the first customers.

Established History of Providing Research and Laboratory Services

CBDV has a history of profitability. Current and past customers are well-established global enterprises who require the cutting-edge cannabis and soon, psilocybin research, which CBDV provides.

Management Expertise

The founding team of CBDV originates from research groups at world-renowned academic institutions. This background instilled an ethos of intellectual curiosity and aspirations of understanding complex concepts through experimentation, research, and analysis.

COMPLEX BIOTECH DIVERSITY VENTURES

A licensed cannabis and psilocybin research laboratory.

Founded by award-winning chemists, CBDV focuses on extraction optimization, analytical testing, and chemical process development to advance the cannabis and psilocybin industries. CBDV was granted a Section 56 exemption from Health Canada to commence their work with psilocybin compounds, allowing the company to possess and research these products for development and quality control before they hit the market.

A Strong IP Portfolio

We offer comprehensive analysis and characterization of the chemical makeup of your cannabis plant material and products to uncover potential blind spots with consistency, purity, and safety.

Established History of Providing Research and Laboratory Services

CBDV has a history of profitability. Current and past customers are well-established global enterprises who require the cutting-edge cannabis and soon, psilocybin research, which CBDV provides.

Management Expertise

The founding team of CBDV originates from research groups at world-renowned academic institutions. This background instilled an ethos of intellectual curiosity and aspirations of understanding complex concepts through experimentation, research, and analysis.

DR MARKUS ROGGEN

Professor Glenn Sammis

PROFESSOR

GLENN SAMMIS

Delic Corp uses cookies to
ensure you get the best experience
on our website. View our Privacy
Policy for more information.